Compare CVS Health Corp (CVS) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Global X Lithium & Battery Tech ETF — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Global X Lithium & Battery Tech ETF trades at $68.96 (market cap $1.49B). The key difference: CVS Health Corp is far larger — about 75.5× Global X Lithium & Battery Tech ETF's market cap, and CVS Health Corp pays a 3.02% dividend while Global X Lithium & Battery Tech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Global X Lithium & Battery Tech ETF for 56 Days on average.
| CVS | LIT | |
|---|---|---|
Market Cap | $112.49B | $1.49B |
Volume | 8,467,392 | 67,221 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $110.60 | $91.62 |
52-Week Low | $70.08 | $53.92 |
Typical Hold Time | 83 Days | 56 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
LIT trades at $69.51, down 2.2% today amid mixed technical signals with a bullish overall rating but bearish moving averages and oscillators. The ETF's recent performance reflects volatility in lithium markets, with short interest dropping 53.1% in September. Key technical levels show support at $70 and resistance at $72. Recent news highlights ongoing EV sector growth with China targeting 30% NEV fleet by 2030, providing long-term tailwinds.
LIT offers exposure to the expanding battery technology sector with catalysts from EV adoption and energy storage demand. However, risks include lithium price volatility and Chinese export controls. The ETF's momentum is supported by semiconductor and AI-driven battery demand, though current technical indicators suggest near-term consolidation may precede further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
